Inpharmatica Licenses Biopendium to Japan s Riken Center | GenomeWeb

NEW YORK, July 17 - Inpharmatica has sold a non-exclusive license to its Biopendium proteome-annotation tool to Japanese structural genomics center Riken, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.